Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading update

17 Feb 2022 07:00

RNS Number : 9270B
Checkit PLC
17 February 2022
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF UK MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

Β 

17 February 2022

Β 

Checkit plc

("Checkit" or the "Group")

Β 

Trading update

Β 

Checkit plc (AIM: CKT), the intelligent operations platform for the deskless worker, provides an unaudited trading update for the year ended 31 January 2022 ("FY22").

Β 

(Β£'m) Reported

Twelve months to

31 January 2022

Actual

31 January 2021

Actual

31 January 2021

Normalised

% Change

Normalised

ARR

8.2

5.7

5.8

+43%

Revenue

Recurring

6.8

5.1

5.2

+31%

Non-recurring

6.5

8.1

9.2

(29) %

Total Group

13.3

13.2

14.4

(7) %

Β 

NOTES

Β 

1. Annual Recurring Revenue ("ARR") is defined as the annual value of recurring revenue relating to contracts that have been installed and are therefore invoiceable. Future revenue relating to bookings taken, but which have not been installed, is excluded from reported ARR.

2. Prior year revenue has been normalised to illustrate revenue that would have been included in the Group's financial results had Tutela LLC (acquired 4 February 2021) been fully owned by the Group throughout both periods.

Β 

The better than expected ARR performance was driven by strong H2 sales bookings.

Β 

The Group delivered bookings growth of 95% in the period, underpinning the Board's confidence in delivering strong ARR growth in FY23 and beyond.

Β 

Recurring revenue includes like-for-like US recurring revenue growth of 82%, driven by the bookings performance noted above. The lag in Group recurring revenue percentage growth, compared to the growth rate of ARR reflects the acceleration in ARR of contracts signed during the second half of the financial year.

Β 

Recurring revenue accounted for 51% of total revenue for the full year. In the last three months of the year, recurring revenue contributed 75% of total revenue as Checkit continued its transformation into a pure software as a service ("SaaS") business.

Β 

Non-recurring revenue declined in line with management's expectations as planned. The Group is now wholly focused on delivering recurring revenue from its technology solutions (including those relating to smart buildings), rather than traditional BEMS one-off projects with minimal software input. In the Group's FY22 results, Checkit will cease reporting the BEMS business as a separate segment and instead will segment recurring and non-recurring revenue.

Β 

Cash and Outlook

Β 

Cash at 31 January 2022 was Β£24.2m (31 January 2021: Β£11.5m), reflecting the recent oversubscribed placing, when the Group raised net proceeds of approximately Β£20.0m. As a result, Checkit is strongly positioned to accelerate its programme of investment, with the intention of achieving further ARR growth in FY23.

Β 

The Board remains confident in the significant opportunities presented by the growing deskless worker industry and a further update will be provided as part of the preliminary results announcement expected to be issued on 28 April 2022.

Β 

Β 

Contacts:

Β 

Checkit plc +44 (0) 1223 643313

www.checkit.net

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial Officer)

Β 

Β Singer Capital Markets (Nominated Adviser & Broker) +44 (0) 20 7496 3000

Β Shaun Dobson / Harry Gooden / George Tzimas

Β 

Forward looking statements

This announcement contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward-looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward-looking statements contained in this announcement are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward-looking statements.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTKQLFFLLLLBBL
Date   Source Headline
29th Jul 20117:01 amRNSAppointment of Chief Financial Officer
29th Jul 20117:00 amRNSResult of AGM and Change of Name
28th Jul 20117:00 amRNSTrading Update
12th Jul 20115:02 pmRNSHolding(s) in Company
30th Jun 20114:58 pmRNSDoc re. Company's Scrip Dividend Scheme
28th Jun 20113:36 pmRNSAnnual Financial Report and Notice of AGM
16th Jun 20111:43 pmRNSHolding(s) in Company
19th May 201110:32 amRNSHolding(s) in Company
16th May 201112:03 pmRNSDirector/PDMR Shareholding
12th May 20117:00 amRNSPreliminary Results
12th Apr 20117:00 amRNSTechnology Update
10th Mar 20117:00 amRNSPre-Close Trading Update
1st Feb 20117:00 amRNSDirector/PDMR Shareholding
31st Jan 201110:24 amRNSDirector/PDMR Shareholding
20th Jan 20119:51 amRNSDirector/PDMR Shareholding and Total Voting Rights
13th Jan 20117:00 amRNSIssue of Equity
17th Dec 20107:00 amRNSTrading Statement
14th Dec 20108:42 amRNSHolding(s) in Company
2nd Dec 20107:00 amRNSHolding(s) in Company
15th Nov 20102:26 pmRNSDirectorate Change
9th Nov 20103:27 pmRNSHolding(s) in Company
5th Nov 20102:24 pmRNSHolding(s) in Company
5th Nov 20107:00 amRNSHolding(s) in Company
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
1st Nov 20104:59 pmRNSHolding(s) in Company
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
5th Oct 20103:47 pmRNSDirector/PDMR Shareholding
27th Sep 20102:26 pmRNSDirector/PDMR Shareholding
24th Sep 20107:00 amRNSCompulsory Acquisition Procedure
23rd Sep 20104:32 pmRNSIssue of Equity
17th Sep 20107:00 amRNSIssue of Equity
16th Sep 20104:42 pmRNSHolding(s) in Company
16th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20101:54 pmRNSDirectorate Change
15th Sep 20107:15 amPRNProposed Cancellation from AIM Close of Offer
15th Sep 20107:00 amRNSOffer Update: Close of Offer
8th Sep 20107:00 amRNSNotification of Interim Results
24th Aug 201011:11 amRNSOffer Document Posted
12th Aug 201012:37 pmRNSDirectorate Change
6th Aug 20102:30 pmRNSDirector/PDMR Shareholding
6th Aug 20102:29 pmRNSHolding(s) in Company
6th Aug 20107:00 amRNSDirectorate Change
6th Aug 20107:00 amRNSHolding(s) in Company
5th Aug 20109:56 amRNSIssue of Equity
2nd Aug 20101:16 pmRNSHolding(s) in Company
30th Jul 20101:00 pmRNSResponse to Offer
30th Jul 20108:45 amRNSForm 8 (OPD) (Hartest Holdings)
30th Jul 20108:37 amRNSOffer for Hartest Holdings
29th Jul 20105:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.